Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
| Image |  |
|---|---|
| Description | scientific article published on 18 June 2019 |
| Author/s |
author: Przemysław Leszek Aldo P. Maggioni |
| Publication date | June 18, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |